In Brief: CibaVision Voltaren ophthalmic
Executive Summary
CibaVision Voltaren ophthalmic: Diclofenac sodium .1% solution adds indication July 23 for photophobia in patients undergoing incisional refractive surgery. Voltaren ophthalmic was first approved for treatment of inflammation following cataract surgery. The SNDA (20-37/S-007) was submitted on Dec. 29, 1994, but pivotal data for the indication were filed in January...